A Study to Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver Cirrhosis

NCT05960006 · clinicaltrials.gov ↗

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Antibiotic Toxicity
Liver Cirrhosis
Renal Insufficiency
Ceftriaxone Overdose
Ascites Hepatic
Infection, Bacterial

Interventions

OTHER: No intervention (observational study)

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Collaborators

[object Object]